TY  - JOUR
AU  - Perez-Molina, J A
AU  - Rubio, R
AU  - Rivero, A
AU  - Pasquau, J
AU  - Suarez-Lozano, I
AU  - Riera, M
AU  - Estebanez, M
AU  - Palacios, R
AU  - Sanz-Moreno, J
AU  - Troya, J
AU  - Mariño, A
AU  - Antela, A
AU  - Navarro, J
AU  - Esteban, H
AU  - Moreno, S
PY  - 2016
DO  - 10.1093/jac/dkw379
UR  - http://hdl.handle.net/10668/10445
T2  - The Journal of antimicrobial chemotherapy
AB  - Objectives: We evaluated whether maintenance therapy with tazanavir/ritonavir plus lamivudine (ATV/r+3TC) was non-inferior to ATV/r plus two nucleosides (ATV/r+2NUCs) at 96 weeks of follow-up. Methods: SALT is a multicentre, open-label,...
LA  - en
PB  - Oxford University Press
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Anti-HIV agents
KW  - Antiretroviral therapy, highly active
KW  - Female
KW  - Humans
KW  - Maintenance chemotherapy
KW  - Male
KW  - Middle aged
KW  - Treatment outcome
KW  - Viral load
KW  - Young adult
TI  - Simplification to dual therapy (atazanavir/ritonavir + lamivudine) versus standard triple therapy [atazanavir/ritonavir + two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study).
TY  - research article
VL  - 72
ER  -